Quality-of-life assessment in the randomized JBCRG-M06/EMERALD study of eribulin plus dual HER2 blockade in HER2-positive locally advanced or metastatic breast cancer.

Saved in:
Bibliographic Details
Title: Quality-of-life assessment in the randomized JBCRG-M06/EMERALD study of eribulin plus dual HER2 blockade in HER2-positive locally advanced or metastatic breast cancer.
Authors: Iwatani T; Department of Breast and Endocrine Surgery, St. Marianna University Hospital, Kanagawa, Japan., Masuda N; Department of Breast Surgery, Graduate School of Medicine, Kyoto University, 54 Shogoin-Kawahara-cho, Sakyo-Ku, Kyoto, 606-8507, Japan. nmasuda@alpha.ocn.ne.jp., Saji S; Department of Medical Oncology, Fukushima Medical University, Fukushima, Japan., Yamaguchi T; Division of Biostatistics, Tohoku University Graduate School of Medicine, Miyagi, Japan., Kojima Y; Institute for Clinical Genetics and Genomics, Showa Medical University, Tokyo, Japan., Kitada M; Department of Breast Disease Center, Asahikawa Medical University Hospital, Hokkaido, Japan., Tada H; Department of Surgery, Division of Breast and Endocrine Surgery, Tohoku University Graduate School of Medicine, Miyagi, Japan.; Division of Breast and Endocrine Surgery, Tohoku Medical and Pharmaceutical University, Miyagi, Japan., Iwasa T; Department of Medical Oncology, Kindai University Hospital, Osaka, Japan., Koizumi K; Department of Surgery 1, Division of Breast Surgery, Hamamatsu University School of Medicine, Shizuoka, Japan., Shigematsu H; Department of Breast Surgery, Hiroshima University Hospital, Hiroshima, Japan., Sagara Y; Department of Breast and Thyroid Surgical Oncology, Social Medical Corporation Hakuaikai, Sagara Hospital, Kagoshima, Japan., Okuno T; Department of Breast Surgery, Kobe City Nishi-Kobe Medical Center, Hyogo, Japan., Hasegawa Y; Department of Breast Surgery, Hachinohe City Hospital, Aomori, Japan., Tokunaga E; Department of Breast Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan., Shien T; Department of Breast and Endocrine Surgery, Okayama University Hospital, Okayama, Japan., Toh U; Department of Breast Surgery, Kurume University Hospital, Fukuoka, Japan., Hasegawa H; Medical HQs, Eisai Co., Ltd., Tokyo, Japan., Osaka S; Medical HQs, Eisai Co., Ltd., Tokyo, Japan., Morita S; Department of Biomedical Statistics and Bioinformatics, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Yamashita T; Department of Breast Surgery and Oncology, Kanagawa Cancer Center, Kanagawa, Japan.
Source: Breast cancer (Tokyo, Japan) [Breast Cancer] 2026 Jun 10. Date of Electronic Publication: 2026 Jun 10.
Publication Type: Journal Article
Journal Info: Publisher: Maruzen Co Country of Publication: Japan NLM ID: 100888201 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1880-4233 (Electronic) Linking ISSN: 13406868 NLM ISO Abbreviation: Breast Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1880-4233
DOI:10.1007/s12282-026-01876-x